Predictors of adverse perinatal outcomes in intrahepatic cholestasis of pregnancy
dc.contributor.author | Çelik, Samettin | |
dc.contributor.author | Çalışkan, Canan S. | |
dc.contributor.author | Çelik, Handan | |
dc.contributor.author | Güçlü, Mehmet | |
dc.contributor.author | Başbuğ, Alper | |
dc.date.accessioned | 2020-04-30T23:21:22Z | |
dc.date.available | 2020-04-30T23:21:22Z | |
dc.date.issued | 2019 | |
dc.department | DÜ, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü | en_US |
dc.description | WOS: 000466963400008 | en_US |
dc.description | PubMed: 31059115 | en_US |
dc.description.abstract | Objectives: Our objective was to evaluate in our clinic the perinatal outcomes of patients diagnosed with ICP based on pre-treatment maternal serum bile acid levels, attempt to identify the risk group and review the literature in light of this information. Material and methods: In total, 370 patients diagnosed with ICP were included in the study, divided into two groups based on the fasting total serum bile acid level before UDCA (Group 1: 10 >= 40 mu mol/L, and Group 2: >= 40 mu mol/L). The groups were examined for clinical characteristics and pregnancy outcomes. Results: It was found that preterm delivery and neonatal intensive care need increased at a serum bile acid cut-off value of 34 mu mol/L. Regardless of serum bile acid, significantly higher rates of meconium-stained amniotic fluid and foetal distress were observed in patients whose diagnoses were made before 34 weeks of gestation. Conclusions: Foetal complications over 40 mu mol/L of serum bile acid were significantly increased. However, slightly lower levels cut-off values (34 mu mol/L) were obtained in terms of preterm birth and neonatal intensive care need. The incidence of meconium-stained amniotic fluid and foetal distress was higher in patients whose diagnosis were made before 34 weeks of gestation. | en_US |
dc.identifier.doi | 10.5603/GP.2019.0039 | en_US |
dc.identifier.endpage | 222 | en_US |
dc.identifier.issn | 0017-0011 | |
dc.identifier.issn | 2543-6767 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 217 | en_US |
dc.identifier.uri | https://doi.org/10.5603/GP.2019.0039 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12684/4182 | |
dc.identifier.volume | 90 | en_US |
dc.identifier.wos | WOS:000466963400008 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | Via Medica | en_US |
dc.relation.ispartof | Ginekologia Polska | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | intrahepatic cholestasis | en_US |
dc.subject | pregnancy | en_US |
dc.subject | perinatal complications | en_US |
dc.title | Predictors of adverse perinatal outcomes in intrahepatic cholestasis of pregnancy | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1
Yükleniyor...
- İsim:
- 4182.pdf
- Boyut:
- 179.47 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin / Full Text